{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:40:08Z","timestamp":1768833608131,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01606"],"award-info":[{"award-number":["PI17\/01606"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01651"],"award-info":[{"award-number":["PI14\/01651"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0012\/0014"],"award-info":[{"award-number":["RD16\/0012\/0014"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI12\/01909"],"award-info":[{"award-number":["PI12\/01909"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0213073","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T19:30:37Z","timestamp":1551382237000},"page":"e0213073","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept"],"prefix":"10.1371","volume":"14","author":[{"given":"Aida","family":"Ferreiro-Iglesias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Perez-Pampin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Raya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Magro-Checa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiannis","family":"Vasilopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Caliz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Joven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8279-3806","authenticated-orcid":true,"given":"Patricia","family":"Carreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Balsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Pascual-Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-7635","authenticated-orcid":true,"given":"Francisco J.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel J.","family":"Moreno-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Manrique-Arija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Carmen","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jose","family":"Alegre-Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Narvaez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Navarro-Sarabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Valor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Garcia-Portales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9913-7688","authenticated-orcid":true,"given":"Ana","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Gomez-Reino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-0606","authenticated-orcid":true,"given":"Antonio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"GR Burmester","year":"2017","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"JS Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/acr.22289","article-title":"Rheumatoid arthritis: a case for personalized health care?","volume":"66","author":"MA Karsdal","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/rheumatology\/kev421","article-title":"Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability","volume":"55","author":"BV Cuppen","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2217\/bmm.15.18","article-title":"Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis","volume":"9","author":"J Oliver","year":"2015","journal-title":"Biomark Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/tpj.2017.26","article-title":"Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis","volume":"17","author":"S Bek","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/hmg\/ddn245","article-title":"Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis","volume":"17","author":"JR Maxwell","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/ard.2009.117622","article-title":"Tumour necrosis factor alpha -308G-&gt;A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis","volume":"69","author":"S Pavy","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2119\/2008-00056.Liu","article-title":"Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis","volume":"14","author":"C Liu","year":"2008","journal-title":"Mol Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar2990","article-title":"Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study","volume":"12","author":"M Suarez-Gestal","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/FPC.0b013e3283544043","article-title":"Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFalpha inhibitors in patients with rheumatoid arthritis","volume":"22","author":"SB Krintel","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/annrheumdis-2012-202405","article-title":"Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis","volume":"72","author":"M Umicevic Mirkov","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.30130","article-title":"Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci","volume":"63","author":"D Plant","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1003394","DOI":"10.1371\/journal.pgen.1003394","article-title":"Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis","volume":"9","author":"J Cui","year":"2013","journal-title":"PLoS Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.27457","article-title":"Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy","volume":"62","author":"J Cui","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/tpj.2015.29","article-title":"Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis","volume":"16","author":"A Ferreiro-Iglesias","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.33381","article-title":"Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort","volume":"64","author":"D Plant","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13075-016-0920-6","article-title":"A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis","volume":"18","author":"K Honne","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/tpj.2015.31","article-title":"A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis","volume":"16","author":"A Julia","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar4504","article-title":"Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis","volume":"16","author":"A Marquez","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/FPC.0000000000000042","article-title":"Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis","volume":"24","author":"A Montes","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13075-015-0571-z","article-title":"Rheumatoid arthritis response to treatment across IgG1 allotype\u2014anti-TNF incompatibility: a case-only study","volume":"17","author":"A Montes","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1038\/ncomms12460","article-title":"Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis","volume":"7","author":"SK Sieberts","year":"2016","journal-title":"Nat Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e0153140","DOI":"10.1371\/journal.pone.0153140","article-title":"Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study","volume":"11","author":"I Ortea","year":"2016","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"D Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cyto.2008.11.008","article-title":"Differences in binding and effector functions between classes of TNF antagonists","volume":"45","author":"T Arora","year":"2009","journal-title":"Cytokine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"ML Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref29","unstructured":"The 1000 Genomes Project Browser. Accessed on: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/browser.1000genomes.org\/index.html\" xlink:type=\"simple\">http:\/\/browser.1000genomes.org\/index.html<\/ext-link>"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","article-title":"Validation of rheumatoid arthritis improvement criteria that include simplified joint counts","volume":"41","author":"AM van Gestel","year":"1998","journal-title":"Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in <italic>R<\/italic> with the <italic>metafor<\/italic> package","volume":"36","author":"W Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"F Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e83555","DOI":"10.1371\/journal.pone.0083555","article-title":"Cytosolic phospholipase A2 regulates TNF-induced production of joint destructive effectors in synoviocytes","volume":"8","author":"RM Sommerfelt","year":"2013","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/pgs.13.60","article-title":"GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis","volume":"14","author":"I Acosta-Colman","year":"2013","journal-title":"Pharmacogenomics"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/pgs.16.16","article-title":"Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort","volume":"17","author":"SL Smith","year":"2016","journal-title":"Pharmacogenomics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1136\/annrheumdis-2014-205541","article-title":"Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis","volume":"74","author":"M Umicevic Mirkov","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/art.39966","article-title":"Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis","volume":"69","author":"J Cui","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Y Okada","year":"2014","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/annrheumdis-2013-204714","article-title":"Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register","volume":"74","author":"K Chatzidionysiou","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-017-1299-8","article-title":"Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies","volume":"19","author":"KA Standish","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1037\/1082-989X.7.1.19","article-title":"On the practice of dichotomization of quantitative variables","volume":"7","author":"RC MacCallum","year":"2002","journal-title":"Psychol Methods"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"P Royston","year":"2006","journal-title":"Stat Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0213073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T07:46:36Z","timestamp":1721029596000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0213073"}},"subtitle":[],"editor":[{"given":"Sevtap","family":"Savas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0213073","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]}}}